Sponsor

Merck Serono S.A.S, France

Clinical research sponsor

Published trials2

Recruiting shown0

Roles1

SourceClinicalTrials.gov

Clinical trials

2 shown

A Multicentre Study of the Efficacy and Safety of Supplementary Treatment With Cholecalciferol in Patients With Relapsing Multiple Sclerosis Treated With Subcutaneous Interferon Beta-1a 44 µg 3 Times WeeklyNCT01198132 · collaborator · 2009-11-01

COMPLETED

Evaluation of Emotional Disorders During Treatment by Interferon Beta in Relapsing-remitting Multiple Sclerosis PatientsNCT01201343 · collaborator · 2005-01-01

COMPLETED

Sponsor roles

collaborator2

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.